Generazione di sottocutaneo e intraepatica umane carcinoma epatocellulare xenotrapianti in topi immunodeficienti

Overview

This article describes protocols for generating human hepatocellular carcinoma (HCC) xenografts in immunodeficient mice. It highlights the process of preparing tumor fragments or cell suspensions for implantation and the subsequent engraftment methods.

Key Study Components

Area of Science

• Cancer Biology
• Xenograft Models
• Hepatocellular Carcinoma

Background

• Human tumor xenografts are essential for studying cancer mechanisms.
• Immunodeficient mice provide a suitable environment for human tumor growth.
• HCC is a prevalent form of liver cancer with significant research implications.
• Partial hepatectomy can enhance intrahepatic engraftment success.

Purpose of Study

• To establish reliable methods for creating HCC xenografts.
• To facilitate the study of tumor biology and therapeutic responses.
• To improve understanding of tumorigenesis in a controlled environment.

Methods Used

• Preparation of tumor fragments or cell suspensions from human HCC specimens.
• Implantation of tumor cells or fragments into subcutaneous or intrahepatic sites.
• Monitoring tumor development in recipient mice over several weeks.
• Utilization of partial hepatectomy to enhance engraftment.

Main Results

• Successful establishment of HCC xenografts in immunodeficient mice.
• Observation of tumor growth and development over time.
• Insights into tumor biology and potential therapeutic responses.
• Demonstration of the efficacy of liver regeneration strategies.

Conclusions

• Human HCC xenografts are valuable for cancer research.
• The methods described can be adapted for various tumor types.
• Further studies can leverage these models to explore novel therapies.

Frequently Asked Questions